goBalto provides an enterprise software-as-a-service platform that manages the early part of clinical trials, helping pharmaceutical companies organize trial sites, find patients, and apply for regulatory approval. The company seeks to replace spreadsheets, email, and phone calls with an intelligent workflow-driven solution. CEO Sujay Jadhav describes the software as "TurboTax for clinical trials," and goBalto says its platform can reduce trial running time by up to 30 percent. The company claims that half of the top pharmaceutical studies use goBalto for at least part of their trials. goBalto plans to use its latest funding to expand global customer service and technical support across 55 countries and to invest in marketing, product development, and engineering. goBalto develops cloud solutions designed to simplify how clinical trials are conducted. Its flagship product, Tracker, is a software-as-a-service clinical research tool that enables trial sponsors and research organizations to track and collaborate on operational data in a transparent, regulatory-compliant, and user-friendly way. The company focuses on supporting clinical study startup and operational workflows. goBalto plans to use its new funding to enhance the platform with new product capabilities to meet the demands of the growing clinical research market. It recently closed a $12M venture funding round, bringing total financing to $21M. goBalto was founded in 2008 and is based in San Francisco, CA. goBalto builds web-based clinical research solutions, centering on Tracker, a purpose-built Software-as-a-Service platform launched in June 2011 that enables sponsors to collaborate with multiple partners in a regulatory-compliant way. Its product aims to streamline workflow, reduce trial startup time and costs, and be intuitive for stakeholders. The company emphasizes cloud deployment and applies Agile and lean startup methodologies to product development. goBalto targets pharmaceutical, biotechnology and medical device companies seeking to lower costs and adjust to regulatory changes. The company plans to use new funding to expand corporate activities and enhance the Tracker platform. Prior financing came from founder Jae Chung and angel investors; the recent financing is a Series A from health-technology investors.

Total raised

$24M

Funding rounds

3

Latest round

Equity

Latest activity

Jan 2015